Furthermore, Met, CD44, and TCF1/7 were also preferentially expressed in BLBC clinical samples while Cyclin D1 was preferentially expressed in luminal breast cancer clinical samples (Fig. 3f and g). This evidence concerns the gene CD44 and breast cancer.